Asthma
RecruitingGB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents
GB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents
- Disease:Asthma
- Substances:–
Germany- Participants:0–17 years · 18–64 years · 65+ years
Rare diseases
Investigational molecules
Locations
GB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents
GermanyComparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk
GermanyVolrustomig in Patients with Unresectable Pleural Mesothelioma and Esophageal Squamous Cell Carcinoma
GermanyAZD0120 versus standard regimens in patients with relapsed or refractory multiple myeloma
GermanyFrexalimab versus Tacrolimus for Prevention of Kidney Transplant Rejection in Adult Kidney Transplant Recipients
GermanyA study of sacituzumab tirumotecan and bevacizumab in patients with newly diagnosed advanced ovarian cancer following first-line platinum-based chemotherapy
GermanyA study to evaluate the safety and effectiveness of pegtibatinase in patients aged 12 to 65 years with classical homocystinuria.
GermanyA study to evaluate the safety and effectiveness of NIO752 in patients with progressive supranuclear palsy
GermanyA study to evaluate the effects of KT-621 in adults with moderate to severe eosinophilic asthma
GermanyA study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.
GermanyA study to evaluate the safety and effectiveness of filgotinib in children and adolescents aged 8 to 17 years with polyarticular juvenile idiopathic arthritis
GermanyStudy of the efficacy and safety of Eloralintide in adults with knee osteoarthritis and overweight or obesity
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.